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Small bowel adenocarcinoma is a rare entity in both adult and paediatric populations. Diagnosis is
usually delayed due to vague symptoms. We report a case of ileal adenocarcinoma presented with
multiple metastases. A 10-year-old Chinese girl presented with recurrent right lower quadrant pain
developed intestinal obstruction. Computerized tomography showed terminal ileum wall thickening, a
pelvic mass and suspicious pulmonary metastases. Laparotomy showed a terminal ileal tumour causing
mechanical obstruction with metastases to the left ovarian and mesenteric lymph nodes. Palliative right
hemi-colectomy with double-barrel ileostomy was performed. The pathology was reported to be ileo-
caecal adenocarcinoma with extensive lymphovascular permeation. She was the started on palliative
chemotherapy with static disease. Diagnosis of small bowel adenocarcinoma remains a challenge to
surgeons as the clinical presentation is subtle in spite of the advanced clinical course. Surgery plays a role
in symptomatic treatment for patients with intestinal obstruction in advanced stage.
 2015 The Authors. Published by Elsevier Inc. All rights reserved.Small bowel tumors are rare amongst all gastrointestinal
malignancies and they usually present in adulthood. The most
common small bowel tumor is lymphoma, followed by adenocar-
cinoma. The time of symptom onset to diagnosis is usually short but
the disease is often advanced at diagnosis. We report a case of a 10-
year-old Chinese girl with small bowel adenocarcinoma with
multiple metastases.1. Case
A 10-year-old girl with unremarkable past health presented
with insidious onset colicky central abdominal pain for 2 weeks,
with localization to right lower quadrant (RLQ) for few days. It was
associated with non-bilious vomiting and watery diarrhea. She
remained afebrile all along but her appetite was markedly reduced.
Examination showed a soft and non-distended abdomen, with mild
tenderness at RLQ. There was no perioral mucosal pigmentation.BY-NC-ND license (http://
ueen Elizabeth Hospital, 30
887.
Leung).
Published by Elsevier Inc. All rightBlood tests on admission were unremarkable. Chest radiograph
(CXR) on admission showed right middle zone consolidation.
The patient was treated as pneumonia but she developed
persistent fever despite multiple antibiotics. Inﬂammatory markers
were not raised. She still complained of intermittent RLQ pain with
episodes of per rectal bleeding. Computed tomography (CT) was
performed which showed ileal wall thickening with subacute in-
testinal obstruction, a pelvic mass at Pouch of Douglas and bilateral
upper lobes consolidation (Figs. 1 and 2).
In order to exclude disseminated tuberculosis, bronchoalveolar
lavage was performed yet yielding no culprit organisms. A positron
emission tomography-computed tomography (PET-CT) was also
performed which showed hot spots at ileocecal and appendiceal
walls with thickening and a pelvic mass suspicious of left ovary
suggestive of tumor inﬁltration. There were extensive hot spots in
both lung ﬁelds. Overall imaging features suggested malignancy.
Differential diagnosis included lymphoma with extensive involve-
ment or gastrointestinal carcinoma with metastasis. A CT-guided
core needle biopsy of the pelvic mass was performed. Histopa-
thology revealed metastatic adenocarcinoma of gastrointestinal
origin. The patient gradually developed abdominal distension and
intolerance to feeding due to worsening intestinal obstruction.
Laparotomy was performed showing a terminal ileal tumor with
extension to cecum causing mechanical obstruction, and thes reserved.
Fig. 1. Axial CT showing transition zone at terminal ileum (arrowhead) and dilated
small bowel loops with ﬂuid levels.
Fig. 2. Axial CT showing left ovarian mass (white arrow) and ascites.
ig. 3. Intra-operative photo showing constricting terminal ileal tumor (yellow arrow)
and swollen appendix (green arrow), with dilated small bowels in the background.
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node metastases were noted and the pelvic mass on CT was
conﬁrmed to be the left ovary. Palliative right hemi-colectomy and
left oophorectomy were performed, and a double-barrel ileostomy
was fashioned. Post-operatively the patient recovered uneventfully
with oral feeding resumed.
Macroscopic pathological examination showed a circumferential
ulcerating tumormeasuring 7.5 2.5 cm (longitudinal transverse)
at the ileocecal junction. Histopathology showed moderately
differentiated adenocarcinoma, stage pT4aN2b (TNM staging, 7th
edition), with extensive lymphovascular permeation. The left ovary
showed metastatic carcinoma. The distal resection margin was
microscopically inﬁltrated by clusters of tumor cells.
Due to the limited experience in managing small bowel
adenocarcinoma, the adult Oncology team was also consulted for
opinion and palliative chemotherapy was started three weeks
after operation according to the A-FOLFIRI protocol. This protocol
included Bevacizumab (Avastin), Folinic acid, 5-Fluorouracil
(5-FU) and Irinotecan. Bevacizumab was withheld until post-
operative 6 weeks. During the initial phase of treatment there
was progressive lung involvement and septic shock due to
Methicillin-sensitive Staphylococcus aureus (MSSA) septicemia,
however the patient recovered well after antibiotic treatment.
After one year of chemotherapy, reassessment PET-CT was per-
formed which showed static lung disease and no hypermetabolic
uptake elsewhere in the body. Distal loopogram showed to distal
obstruction in the stoma and the patient was scheduled for stoma
closure.
2. Discussion
Small bowel tumors represent 1e5% of all primary gastrointes-
tinal tumors in adults. About 25e50% of small bowel tumors are
adenocarcinoma, and the mean age of diagnosis is 65 years old.
Both sexes appear to be equally affected [1e3]. The overall inci-
dence of gastrointestinal tract tumor in the pediatric population
was reported to be 1.1/million/year. The most common type is non-
Hodgkin’s lymphoma (incidence 0.9/million/year), followed by
adenocarcinoma (0.14/million/year) [4]. The appendix is also a
common site for carcinoid tumor, however most of them are inci-
dental ﬁnding after appendicectomy for appendicitis. In a review
performed by Gutierrez JC et al., about 15% of carcinoid tumors
originate from the appendix, and the peak age of presentation is at
adolescence (15e19 years) [5]. In another outcome study by
Mahendraraj and Chamberlain, the mean age of presentation ofappendiceal carcinoid was 15.3 years which also echoed with
Gutierrez’s ﬁndings, and they also found that the pediatric popu-
lation had more locoregional disease that the adult population [6].
Common presentations of small bowel tumors include recurrent
abdominal pain, weight loss and gastrointestinal bleeding. Un-
common presentations include intussusception and intestinal
perforation which necessitate emergency surgery [1,7e9]. The
ileum was the most commonly involved area for small bowel tu-
mors [2], and thus the initial presentation might mimic other
common surgical pathologies such as acute appendicitis and in-
ﬂammatory bowel disease. In our case the patient had right lower
quadrant pain resembling acute appendicitis. Apart from the ter-
minal ileal tumor, the appendix was found swollen intraoperatively
due to malignant inﬁltration. It could possibly explain why the
patient suffered from recurrent RLQ pain.
Several conditions have been identiﬁed to be associated with
small bowel adenocarcinoma. The strongest association is Crohn’s
disease, with extensive literature reviewing the epidemiology and
other related aspects [10e13]. Other associated diseases include
celiac disease, familial adenomatous polyposis and Peutz-Jehgers
syndrome [14]. Our case did not have any inherited conditions
which may predispose her to small bowel adenocarcinoma, and
clinical examination did not reveal any signs suggestive of such
congenital disease.
The prognosis of small bowel adenocarcinoma is poor, with a 5-
year survival rate of 18e34% [1,7]. Zar N et al. reported a sexual
difference for 5-year survival rates for jejunal or ileal tumors be-
tween women and men, being 52% and 40% respectively, but such
difference was not identiﬁed for duodenal tumors [15]. The poorF
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Lymph node metastases were found in up to 45% and vascular in-
vasion in 19% of patients with small bowel tumors [7]. In our case
metastases were evident at mesenteric lymph nodes, left ovary and
both lungs.
Due to the rarity of the disease in the pediatric population, no
standard treatment regimen has been recommended for metastatic
small bowel adenocarcinoma. Treatment strategies had been
extrapolated from adult experience and experience in treatment of
colorectal carcinoma. The most common chemotherapy regimens
include FOLFOX (Folinic acid, 5-FU and Oxaliplatin) and FOLFIRI
(Folinic acid, 5-FU and Irinotecan) [16,17]. The addition of Bev-
acizumab to FOLFIRI regimen has also been proven to improve
statistical and clinical survival among patients with metastatic
colorectal cancer. Hence the A-FOLFIRI regimen was chosen for our
patient in view of the survival beneﬁts. However careful monitoring
of blood counts due to long-term use of Irinotecan must be done
due to the possibility of neutropenia, which unfortunately
happened in our patient and led to MSSA septicaemia requiring
admission to the Intensive Care Unit.
3. Conclusion
We report the youngest case of metastatic small bowel adeno-
carcinoma in English literature. Diagnosis and treatment remains a
challenge as the disease is usually advanced at presentation and can
be complicated by intestinal obstruction. Palliative surgery plays a
role in symptomatic relief for patients at advanced stage.
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